Show simple item record

dc.contributor.authorFaridi, S
dc.contributor.authorShamsipour, M
dc.contributor.authorKrzyzanowski, M
dc.contributor.authorKunzli, N
dc.contributor.authorAmini, H
dc.contributor.authorAzimi, F
dc.contributor.authorMalkawi, M
dc.contributor.authorMomeniha, F
dc.contributor.authorGholampour, A
dc.contributor.authorHassanvand, MS
dc.contributor.authorNaddafi, K
dc.date.accessioned2018-08-26T07:11:38Z
dc.date.available2018-08-26T07:11:38Z
dc.date.issued2018
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/44405
dc.description.abstractThe main objectives of this study were (1) investigation of the temporal variations of ambient fine particulate matter (PM2.5) and ground level ozone (O-3) concentrations in Tehran megacity, the capital and most populous city in Iran, over a 10-year period from 2006 to 2015, and (2) estimation of their long-term health effects including all-cause and cause-specific mortality. For the first goal, the data of PM2.5 and O-3 concentrations, measured at 21 regulatory monitoring network stations in Tehran, were obtained and the temporal trends were investigated. The health impact assessment of PM2.5 and O-3 was performed using the World Health Organization (WHO) AirQ+ software updated in 2016 by WHO European Centre for Environment and Health. Local baseline incidences in Tehran level were used to better reveal the health effects associated with PM2.5 and O-3. Our study showed that over 2006-2015, annual mean concentrations of PM2.5 and O-3 varied from 24.7 to 38.8 mu g m(-3) and 35.4 to 76.0 mu g m(-3), respectively, and were significantly declining in the recent 6 years (2010-2015) for PM2.5 and 8 years (2008-2015) for O-3. However, Tehran citizens were exposed to concentrations of annual PM2.5 exceeding the WHO air quality guideline (WHO AQG) (10 mu g m(-3)), U.S. EPA and Iranian standard levels (12 mu g m(-3)) during entire study period. We estimated that long-term exposure to ambient PM2.5 contributed to between 24.5% and 36.2% of mortality from cerebrovascular disease (stroke), 19.8% and 24.1% from ischemic heart disease (IHD), 13.6% and 19.2% from lung cancer (LC), 10.7% and 15.3% from chronic obstructive pulmonary disease (COPD), 15.0% and 25.2% from acute lower respiratory infection (ALRI), and 7.6% and 11.3% from all-cause annual mortality in the time period. We further estimated that deaths from IHD accounted for most of mortality attributable to long-term exposure to PM2.5. The years of life lost (YLL) attributable to PM2.5 was estimated to vary from 67,970 to 106,706 during the study period. In addition, long-term exposure to O-3 was estimated to be responsible for 0.9% to 2.3% of mortality from respiratory diseases. Overall, long-term exposure to ambient PM2.5 and O-3 contributed substantially to mortality in Tehran megacity. Air pollution is a modifiable risk factor. Appropriate sustainable control policies are recommended to protect public health.
dc.language.isoEnglish
dc.relation.ispartofENVIRONMENT INTERNATIONAL
dc.subjectPM2.5
dc.subjectO-3
dc.subjectTemporal variability
dc.subjectHealth burden
dc.subjectTehran
dc.titleLong-term trends and health impact of PM2.5 and O-3 in Tehran, Iran, 2006-2015
dc.typeArticle
dc.citation.volume114
dc.citation.spage37
dc.citation.epage49
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.1016/j.envint.2018.02.026


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record